As of Mar 27
| -0.10 / -2.35%|
The 1 analysts offering 12-month price forecasts for VolitionRX Ltd have a median target of 6.00, with a high estimate of 6.00 and a low estimate of 6.00. The median estimate represents a +44.58% increase from the last price of 4.15.
The current consensus among 1 polled investment analysts is to Buy stock in VolitionRX Ltd. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.